Allergic Asthma Biomarkers Using Systems Approaches
Overview
Affiliations
Asthma is characterized by lung inflammation caused by complex interaction between the immune system and environmental factors such as allergens and inorganic pollutants. Recent research in this field is focused on discovering new biomarkers associated with asthma pathogenesis. This review illustrates updated research associating biomarkers of allergic asthma and their potential use in systems biology of the disease. We focus on biomolecules with altered expression, which may serve as inflammatory, diagnostic and therapeutic biomarkers of asthma discovered in human or experimental asthma model using genomic, proteomic and epigenomic approaches for gene and protein expression profiling. These include high-throughput technologies such as state of the art microarray and proteomics Mass Spectrometry (MS) platforms. Emerging concepts of molecular interactions and pathways may provide new insights in searching potential clinical biomarkers. We summarized certain pathways with significant linkage to asthma pathophysiology by analyzing the compiled biomarkers. Systems approaches with this data can identify the regulating networks, which will eventually identify the key biomarkers to be used for diagnostics and drug discovery.
Particles in Exhaled Air (PExA): Clinical Uses and Future Implications.
Roe T, Silveira S, Luo Z, Osborne E, Senthil Murugan G, Grocott M Diagnostics (Basel). 2024; 14(10).
PMID: 38786270 PMC: 11119244. DOI: 10.3390/diagnostics14100972.
An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks.
Alfaro-Garcia J, Granados-Alzate M, Vicente-Manzanares M, Gallego-Gomez J Cells. 2021; 10(11).
PMID: 34831086 PMC: 8616224. DOI: 10.3390/cells10112863.
The application of proteomics in the diagnosis and treatment of bronchial asthma.
Xu P, Wang L, Chen D, Feng M, Lu Y, Chen R Ann Transl Med. 2020; 8(4):132.
PMID: 32175425 PMC: 7048998. DOI: 10.21037/atm.2020.02.30.
Pilot-Scale Study Of Human Plasma Proteomics Identifies ApoE And IL33 As Markers In Atopic Asthma.
Bhowmik M, Majumdar S, Dasgupta A, Bhattacharya S, Saha S J Asthma Allergy. 2019; 12:273-283.
PMID: 31571934 PMC: 6759800. DOI: 10.2147/JAA.S211569.
Soluble CD93 as a Novel Biomarker in Asthma Exacerbation.
Sigari N, Jalili A, Mahdawi L, Ghaderi E, Shilan M Allergy Asthma Immunol Res. 2016; 8(5):461-5.
PMID: 27334785 PMC: 4921701. DOI: 10.4168/aair.2016.8.5.461.